ResearcherHokkaido UniversityNo recent work listed
Toshihiro Kushibiki
Matched on ORCID iD 0000-0002-1705-1467; OpenAlex author ID A5103054717. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 4
- Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. Co-author DOI 10.1158/1535-7163.mct-19-0491↗
- Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Co-author DOI 10.1038/s41417-018-0020-7↗
- Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. Co-author DOI 10.18632/oncotarget.21939↗
- Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice. Co-author DOI 10.18632/oncotarget.5729↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuho Inoko · 4 shared papers, 2015–2020 · strength 0.25
- Paper Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. DOI 10.1158/1535-7163.mct-19-0491↗
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Takahiro Tsuchikawa · 4 shared papers, 2015–2020 · strength 0.25
- Paper Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. DOI 10.1158/1535-7163.mct-19-0491↗
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Toru Nakamura · 4 shared papers, 2015–2020 · strength 0.25
- Paper Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. DOI 10.1158/1535-7163.mct-19-0491↗
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Satoshi Hirano · 4 shared papers, 2015–2020 · strength 0.25
- Paper Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. DOI 10.1158/1535-7163.mct-19-0491↗
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Toshiaki Shichinohe · 3 shared papers, 2015–2020 · strength 0.19
- Paper Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target. DOI 10.1158/1535-7163.mct-19-0491↗
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopi… DOI 10.18632/oncotarget.5729↗
- Hironobu Takano · 3 shared papers, 2015–2018 · strength 0.16
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Paper Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopi… DOI 10.18632/oncotarget.5729↗
- Shoki Sato · 3 shared papers, 2015–2018 · strength 0.16
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Paper Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopi… DOI 10.18632/oncotarget.5729↗
- Shintaro Takeuchi · 3 shared papers, 2015–2018 · strength 0.16
- Paper Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. DOI 10.1038/s41417-018-0020-7↗
- Paper Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. DOI 10.18632/oncotarget.21939↗
- Paper Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopi… DOI 10.18632/oncotarget.5729↗
- Yoshitsugu Nakanishi · 1 shared paper, 2020 · strength 0.08
- Toshimichi Asano · 1 shared paper, 2020 · strength 0.08
- Shinya Tanaka · 1 shared paper, 2020 · strength 0.08
- Kyoko Hida · 1 shared paper, 2020 · strength 0.08
- Osamu Sato · 1 shared paper, 2017 · strength 0.05
- Shota Kuwabara · 1 shared paper, 2017 · strength 0.05
- Yusuke Nakamura · 1 shared paper, 2017 · strength 0.05
- Masato Ono · 1 shared paper, 2017 · strength 0.05
- Hiroshi Nishihara · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.